Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 37 EP applications Andrea Josephine Strang has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 17, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12710794

FLUOROPHENYL BICYCLIC HETEROARYL COMPOUNDS

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/04, C07D 519/00
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12718554

17ALPHA-HYDROXYLASE/C17,20-LYASE INHIBITORS

IPC classification:
A61K 31/4436, A61K 31/4439, A61K 31/444, A61K 31/506, A61P 35/00, C07D 401/04, C07D 401/14, C07D 405/04, C07D 409/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12730043

HETEROCYCLIC SULFONAMIDE DERIVATIVES

IPC classification:
A61K 31/343, A61P 35/00, C07D 307/82
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12728089

CYCLOHEXYL ISOQUINOLINONE COMPOUNDS

IPC classification:
A61K 31/47, A61P 35/00, C07D 217/04, C07D 405/08
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12772493

BICYCLIC HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

IPC classification:
A61K 31/4162, A61K 31/4188, A61P 9/12, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12769172

6 - SUBSTITUTED 3 - (QUINOLIN- 6 - YLTHIO) - [1,2,4]TRIAZOLO [4, 3 -A]PYRADINES AS TYROSINE KINASE

IPC classification:
A61K 31/437, A61P 29/00, A61P 35/00, C07D 471/04, C07D 519/00
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12780535

CHOLINE SALT OF AN ANTI - INFLAMMATORY SUBSTITUTED CYCLOBUTENEDIONE COMPOUND

IPC classification:
A61K 31/18, A61P 29/00, C07C 215/40, C07C 311/48
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP12805775

PYRAZOLOPYRROLIDINE COMPOUNDS

IPC classification:
A61K 31/4162, A61K 31/4439, A61K 31/506, A61K 31/513, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12813983

CYCLIC UREA DERIVATIVES AS ANDROGEN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4184, A61K 31/4188, A61P 5/26, A61P 35/00, C07D 235/02, C07D 235/26, C07D 401/04, C07D 401/12, C07D 401/14, C07D 405/04, C07D 405/12, C07D 409/04, C07D 491/052
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805897

COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS

IPC classification:
A61K 31/4725, A61K 31/501, A61K 31/506, A61K 31/513, A61K 31/519, A61P 35/00, C07D 401/10, C07D 401/14, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/04, C07D 513/02
Applicant:
Novartis AG
Agent:
D Young & Co LLP
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805893

COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS

IPC classification:
A61K 31/4725, A61P 35/00, C07D 401/10, C07D 401/14, C07D 405/14, C07D 409/14, C07D 413/14
Applicant:
Novartis AG
Agent:
D Young & Co LLP
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805896

COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS

IPC classification:
A61K 31/4725, A61P 35/00, C07D 401/10
Applicant:
Novartis AG
Agent:
D Young & Co LLP
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805895

COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS

IPC classification:
A61K 31/4725, A61P 35/00, C07D 401/10, C07D 409/14
Applicant:
Novartis AG
Agent:
D Young & Co LLP
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805894

COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS

IPC classification:
A61K 31/4725, A61K 31/496, A61P 35/00, C07D 401/10, C07D 401/14, C07D 413/14
Applicant:
Novartis AG
Agent:
D Young & Co LLP
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13711952

IMIDAZOPYRROLIDINONE COMPOUNDS

IPC classification:
A61K 31/4188, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP12729549

HYDROXY SUBSTITUTED ISOQUINOLINONE DERIVATIVES AS P53 (MDM2 OR MDM4) INHIBITORS

IPC classification:
A61K 31/47, A61P 35/00, C07D 217/24, C07D 401/04, C07D 401/10, C07D 401/14, C07D 405/10, C07D 405/14, C07D 409/10, C07D 413/08, C07D 451/02, C07D 451/14, C07D 491/08, C07D 493/08
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13734183

PYRROLOPYRROLIDINONE COMPOUNDS

IPC classification:
A61K 31/407, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The patent has been granted
EP13814360

PYRIDONE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF TUBERCULOSIS

IPC classification:
A61K 31/4412, A61P 31/06, C07D 213/64, C07D 401/06, C07D 405/06
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
PATENT GRANTED
EP12700840

SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES

IPC classification:
A61K 31/444, A61K 31/505, A61K 31/553, A61P 9/00, A61P 29/00, A61P 31/18, A61P 35/00, A61P 37/00, C07D 213/74, C07D 401/04, C07D 405/14, C07D 413/14, C07D 491/107
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14703441

SUBSTITUTED PURINONE COMPOUNDS

IPC classification:
C07D 473/28
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
PATENT GRANTED
EP14704909

PYRAZOLO[3,4-D]PYRIMIDINONE COMPOUNDS AS INHIBITORS OF THE P53/MDM2 INTERACTION

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14708992

BENZOTHIOPHENE DERIVATIVES AND COMPOSITIONS THEREOF AS SELECTIVE ESTROGEN RECEPTOR DEGRADERS

IPC classification:
A61K 31/381, A61P 35/00, C07D 333/64, C07D 333/66, C07D 409/04, C07D 409/10, C07D 409/12, C07D 413/04, C07D 413/12, C07D 417/12
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11796696

DIMERIC IAP INHIBITORS

IPC classification:
A61K 31/4439, A61P 35/00, C07D 401/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14728350

PYRAZOLO-PYRROLIDIN-4-ONE DERIVATIVES AS BET INHIBITORS AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61K 31/4162, A61K 31/437, A61P 35/00, C07D 487/04, C07D 519/00
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The patent has been granted
EP14731799

PYRAZOLOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61K 31/4162, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
PATENT GRANTED
EP14741368

PYRAZOLO-PYRROLIDIN-4-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61K 31/4439, A61K 31/444, A61K 31/506, A61P 3/00, A61P 31/00, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
The patent has been granted
EP14731798

IMIDAZOPYRROLIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61K 31/4188, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11796695

DIMERIC IAP INHIBITORS

IPC classification:
A61K 31/4439, A61P 35/00, C07D 401/12
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12704039

[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE COMPOUNDS AS INHIBITORS OF THE C-MET TYROSINE KINASE

IPC classification:
A61K 31/5025, A61P 29/00, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11811150

BI-HETEROARYL COMPOUNDS AS VPS34 INHIBITORS

IPC classification:
A61K 31/505, A61P 35/00, C07D 239/42, C07D 401/12
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16161001

IMIDAZOPYRROLIDINONE COMPOUNDS

IPC classification:
A61K 31/4188, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14812645

PYRROLOPYRROLONE DERIVATIVES AND THEIR USE AS BET INHIBITORS

IPC classification:
A61K 31/407, A61P 35/00, C07D 487/04, C07D 519/00
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15703106

1 -(TRIAZIN-3-YI_/PYRIDAZIN-3-YL)-PIPER(-AZINE)IDINE DERIVATIVES AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61K 31/495, A61P 35/04, C07D 241/26, C07D 249/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP15703105

1 -PYRIDAZIN-/TRIAZIN-3-YL-PIPER(-AZINE)/IDINE/PYROLIDINE DERIVATIVES AND AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61K 31/4965, A61K 31/505, C07D 239/48, C07D 241/26, C07D 249/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP15703321

N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61K 31/495, A61P 35/04, C07D 241/18, C07D 241/20
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15766661

COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS

IPC classification:
A61K 31/501, A61P 35/00, C07D 305/06, C07D 405/12, C07D 405/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made
EP15766660

COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS

IPC classification:
A61K 31/5377, A61P 35/00, C07D 213/74, C07D 403/12, C07D 413/04, C07D 413/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made

Please Sign in to use this feature